"BRAF Inhibition Opens Door to Development of Combination Targeted Therapy in Melanoma"

Starts: 1:45 pm on Friday, October 12, 2012
Ends: 2:45 pm on Friday, October 12, 2012
Location: 670 Albany Street Room #107/108
URL: http://www.bumc.bu.edu/busm-pathology/files/2008/09/Seminar-Fall-2012.pdf
Contact Name: Deb Kiley
Contact Email: debra.kiley@bmc.org
Contact Phone: 617 414 7914

Department of Pathology and Laboratory Medicine Seminar Series. Speaker - Keith T. Flaherty, MD Director of Developmental Therapeutics Massachusetts General Hospital Cancer Center Harvard Medical School